Welcome to our dedicated page for Bed Bath & Beyond SEC filings (Ticker: BBBY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Bed Bath & Beyond, Inc. (NYSE: BBBY) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including current reports on Form 8-K and related exhibits. These filings offer detailed insight into Bed Bath & Beyond’s strategy as an ecommerce-focused "Everything Home" company with home retail brands and a blockchain asset portfolio.
In its Form 8-K filings, Bed Bath & Beyond reports on a range of material events. These include merger and acquisition agreements, such as the Agreement and Plan of Merger under which a wholly owned subsidiary of Bed Bath & Beyond will merge with The Brand House Collective, Inc., subject to customary closing conditions. The filing describes the exchange ratio, treatment of equity awards, conditions to closing, termination rights, and potential termination fees, giving investors a structured view of the proposed transaction.
Other 8-Ks detail credit and financing arrangements, including an Amended and Restated Term Loan Credit Agreement and subsequent amendments with The Brand House Collective, delayed-draw term loan commitments that are convertible into equity, and additional commitments disclosed in later amendments. Filings also describe Bed Bath & Beyond’s participation in loans issued by The Container Store, Inc. via participation agreements, outlining aggregate purchase prices and the rights to interest and repayment associated with these positions.
Capital markets actions are another key focus of the company’s SEC disclosures. Bed Bath & Beyond has filed materials related to a warrant dividend distribution to shareholders, including a Warrant Agreement, registration statements for shares issuable upon exercise of the warrants, and detailed terms covering exercise price, expiration, early expiration conditions, and listing applications for the warrants under the ticker BBBY WS.
Filings further cover corporate governance and compensation matters, such as the adoption of the 2025 Employment Inducement Equity Incentive Plan under NYSE Rule 303A.08, and the appointment of Marcus Lemonis as Chief Executive Officer in addition to his role as Executive Chairman and principal executive officer. Results of operations and financial condition are furnished through earnings-related 8-Ks, which reference press releases and presentations with quarterly financial data and key operating metrics.
On Stock Titan, these filings are updated as they are released on EDGAR. AI-powered summaries help explain the significance of each document, from merger agreements and credit amendments to warrant distributions and executive appointments, so users can more quickly understand how each filing relates to Bed Bath & Beyond’s home-focused retail, services, and blockchain strategy.
Bed Bath & Beyond, Inc. has completed its previously announced all-stock acquisition of The Brand House Collective, making TBHC a wholly owned subsidiary. TBHC shareholders received 0.1993 shares of BBBY common stock for each TBHC share, with cash paid instead of fractional BBBY shares based on a $4.66 reference price.
The company also agreed to contribute $30,000,000 of capital to TBHC for general corporate purposes, including repaying a portion of TBHC’s debt to Bank of America. Outstanding TBHC stock options and restricted stock units were converted into BBBY equity or cancelled in accordance with specified price and vesting terms.
Bed Bath & Beyond, Inc. entered into a Merger Agreement to acquire The Container Store Holdings, LLC, with Falcon Merger Sub, LLC merging into TCS so it becomes a wholly owned subsidiary. The transaction uses a $150,000,000 purchase price funded through a mix of senior convertible notes and common stock priced at $7.00 per share, subject to caps on total share issuance and substitution of additional notes when equity limits are reached.
The company arranged lender consents, a transaction support agreement with TCS equity and term loan holders, and a put agreement tied to up to $30,000,000 of new 2026-2 term loans. Buyer Convertible Notes will bear 5.00% interest, potentially stepping up to 10.00% and 12.00% if required stockholder approval for full conversion is delayed, and convert initially at 109.8901 shares per $1,000 principal (about $9.10 per share). The shareholder letter states a goal of at least $40 million of annualized cost savings within 12 to 18 months from integrating Kirkland’s, The Container Store, Elfa, and Closet Works.
Leadership changes accompany the strategy: Brian LaRose will become Chief Financial Officer, Amy Sullivan will become President, and Lisa Foley will become Chief Operating Officer, each under new employment agreements with performance-based equity incentives and change-in-control severance protections, while current CFO Adrianne Lee and Chief Accounting Officer Leah Putnam will depart.
Bed Bath & Beyond, Inc. is asking stockholders to vote at its virtual 2026 annual meeting on May 14, 2026. Holders of 69,342,333 shares outstanding as of March 17, 2026 can attend online and have one vote per share.
Stockholders will vote on electing seven directors, ratifying KPMG as independent auditor for 2026, and an advisory “say on pay” for named executive officer compensation. They are also asked to approve doubling authorized common stock from 100,000,000 to 200,000,000 shares, which would expand capacity for financings, equity awards, and strategic transactions.
The proxy seeks approval of an adjournment right if more time is needed to pass the share increase or equity plan items, and a major amendment and restatement of the 2005 Equity Incentive Plan. The Restated Plan would add 4,291,000 new shares, taking 4,679,179 shares available for future awards before further grants and recycling, and would lift individual annual limits on options, RSUs, restricted stock and performance shares to 2,000,000 each.
As of March 10, 2026, equity awards and available shares represented about 5.4% fully diluted overhang; if the Restated Plan is approved, overhang would rise to about 10.6% before future usage. The company has granted “Contingent Awards” that depend on stockholder approval, including 1,500,000 RSUs and 600,000 performance shares (at target) to CEO Marcus Lemonis, plus 39,944 RSUs and 243,840 performance shares (at target) for other executives and employees.
Bed Bath & Beyond Inc — The Vanguard Group amended its Schedule 13G/A reporting that it beneficially owns 0 shares of Common Stock as of 03/13/2026. The filing notes an internal realignment effective 01/12/2026 and states holdings reported herein would be in the form of warrants; the reporting entity has disaggregated subsidiary reporting per SEC Release No. 34-39538.
Bed Bath & Beyond, Inc. is soliciting proxies for its 2026 Annual Meeting to be held virtually on May 14, 2026. Stockholders of record as of March 17, 2026 may vote on director elections and six proposals.
Key items include a proposal to increase authorized common shares from 100,000,000 to 200,000,000, an amendment and restatement of the 2005 Equity Incentive Plan adding 4,291,000 newly authorized shares (resulting in 4,679,179 shares available as of the Restatement Effective Date), and contingent equity awards totaling 1,539,944 RSUs and 843,840 performance shares granted March 11, 2026, subject to stockholder approval. The filing discloses 69,334,797 shares outstanding as of March 10, 2026 and estimates fully-diluted overhang rising from 5.4% to approximately 10.6% if the Restated Plan is approved.
Bed Bath & Beyond director Joseph J. Tabacco Jr. reported an open-market purchase of 20,000 shares of Common Stock at a weighted average price of $5.11 per share. The shares were bought on March 10, 2026 in multiple trades between $5.07 and $5.13 per share.
The purchase was made indirectly through the Joseph Tabacco and Peggy Schmidt Revocable Trust, where he is trustee and beneficiary. After this transaction, the trust held 167,209 shares, and he also held 11,506 shares directly.
The filing also notes previously issued warrants from October 7, 2025, covering 1,150 shares directly and 14,720 shares indirectly, each exercisable for one share of common stock at an exercise price of $15.50 per warrant, with an expiration date of October 7, 2026.
Lee Adrianne reported acquisition or exercise transactions in this Form 4 filing.
Bed Bath & Beyond, Inc. President & CFO Adrianne Lee received a grant of 100,000 restricted stock units (RSUs), each representing a contingent right to one share of common stock. This is a compensation-related award, not an open-market stock purchase or sale.
The RSUs vest in three equal installments at the close of business on February 17, 2027, February 17, 2028 and February 17, 2029. Vested shares will be delivered to Lee promptly after each vesting date, and the 100,000 RSUs shown reflect the amount from this grant beneficially owned following the reported transaction.
Putnam Leah R reported acquisition or exercise transactions in this Form 4 filing.
BED BATH & BEYOND, INC. Chief Accounting Officer Leah R. Putnam reported receiving a grant of 40,000 restricted stock units (RSUs), each representing a right to one share of common stock. These RSUs vest in three equal installments on February 17, 2027, February 17, 2028, and February 17, 2029, with shares delivered promptly after each vesting date. Following this grant, she beneficially owns 40,000 RSUs from this award.
Bed Bath & Beyond executive chairman and CEO Marcus Lemonis reported a series of equity compensation transactions on March 10, 2026. He exercised 166,666 restricted stock units and 141,432 performance shares into an equal number of common shares at a conversion price of $0.00 per share.
He also received common stock awards of 166,666 and 141,432 shares, while 59,813 and 34,680 shares were withheld at $4.91 per share to cover tax obligations. After these vesting and tax-withholding transactions, Lemonis directly holds 669,756 shares of Bed Bath & Beyond common stock.
Bed Bath & Beyond Chief Accounting Officer Leah R. Putnam reported routine equity compensation activity. On March 2, 2026, 1,000 restricted stock units were exercised into 1,000 shares of common stock at a price of $0.00 per share. As part of the same event, 244 shares of common stock at $5.18 per share were withheld to cover tax obligations. Each restricted stock unit represents one share of common stock and vested in three equal installments on March 2, 2024, March 2, 2025 and March 2, 2026. Following these transactions, Putnam directly owned 16,554 shares of Bed Bath & Beyond common stock.